Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.


About Marc Davis

Marc Davis
Marc Davis,
Former floor trader, investment industry research analyst, journalist & CBC TV business reporter, Marc is steeped in news media & capital markets ...

Marc Davis's Most Recent Articles

Canagold: Sweet Surprise as a High-Grade Low-Cost Gold Deposit Delivers

It’s a big shot in the arm that promises to redouble the considerable scarcity value of the New...

Marc Davis | September 22, 2021

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID...

Marc Davis | August 4, 2021

Kodiak Copper: Why Scarcity and Size Matter Most

Location, location, location! So goes the time-honoured adage about the three golden rules of...

Marc Davis | July 7, 2021

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern...

Marc Davis | June 28, 2021

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp....

Marc Davis | June 10, 2021

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a...

Marc Davis | June 3, 2021

Arctic Star: My Next HOME RUN?

Can I hit the ball out of the park once again? More specifically, can I identify a hidden gem...

Marc Davis | May 20, 2021

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately...

Marc Davis | May 11, 2021

Why the US is Backing American Lithium

It’s a strategically symbolic investment that clearly demonstrates the US government’s...

Marc Davis | April 30, 2021

Sierra Madre Gold & Silver: Mining’s Next Star Performer?

As the US economy bounces back, confident and emboldened investors are rushing back into...

Marc Davis | April 28, 2021
1 2 3 4 5 6 7 8 9 10 ... Next